Manager × security

ARMISTICE CAPITAL, LLC IMVT holdings history

Who else holds this security?

IMMUNOVANT INC · CUSIP 45258J102 · CIK 1601086

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, ARMISTICE CAPITAL, LLC reported 1.74M IMVT (shares), valued at $66.89M, or 1.85% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources
Portfolio weight and quantity history
Reported portfolio weight
1.85%
Shares
1.74M
1,736,000
Reported value
$66.89M
USD

Shares decreased 51.30%; reported value decreased 24.47%, and weight changed -1.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.85%1,736,000SEC filingFiled Aug 14, 2026
Q1 20262.92%3,564,916SEC filingFiled May 15, 2026
Q4 20253.58%5,747,155SEC filingFiled Feb 17, 2026
Q3 20252.95%5,836,000SEC filingFiled Nov 17, 2025
Q2 20253.15%5,200,000SEC filingFiled Aug 14, 2025
Q1 20252.06%4,500,000SEC filingFiled May 15, 2025
Q4 20242.23%3,870,586SEC filingFiled Feb 14, 2025
Q3 20242.65%3,548,000SEC filingFiled Nov 14, 2024
Q2 20242.35%3,396,909SEC filingFiled Aug 14, 2024
Q1 20241.86%2,164,000SEC filingFiled May 15, 2024
Q4 20231.61%1,436,000SEC filingFiled Feb 13, 2024
Q3 20231.18%1,035,877SEC filingFiled Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20231.18%1,035,877$39.77MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing
Filed Nov 14, 2023
Q4 20231.61%1,436,000$60.50MShares increased 38.63%; reported value increased 52.13%, and weight changed +0.43 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 13, 2024
Q1 20241.86%2,164,000$69.92MShares increased 50.70%; reported value increased 15.57%, and weight changed +0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 15, 2024
Q2 20242.35%3,396,909$89.68MShares increased 56.97%; reported value increased 28.26%, and weight changed +0.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2024
Q3 20242.65%3,548,000$101.15MShares increased 4.45%; reported value increased 12.80%, and weight changed +0.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 14, 2024
Q4 20242.23%3,870,586$95.87MShares increased 9.09%; reported value decreased 5.22%, and weight changed -0.42 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 14, 2025
Q1 20252.06%4,500,000$76.91MShares increased 16.26%; reported value decreased 19.79%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 15, 2025
Q2 20253.15%5,200,000$83.20MShares increased 15.56%; reported value increased 8.19%, and weight changed +1.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2025
Q3 20252.95%5,836,000$94.08MShares increased 12.23%; reported value increased 13.07%, and weight changed -0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 17, 2025
Q4 20253.58%5,747,155$146.09MShares decreased 1.52%; reported value increased 55.29%, and weight changed +0.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 17, 2026
Q1 20262.92%3,564,916$88.55MShares decreased 37.97%; reported value decreased 39.39%, and weight changed -0.66 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 15, 2026
Q2 20261.85%1,736,000$66.89MShares decreased 51.30%; reported value decreased 24.47%, and weight changed -1.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2026
ARMISTICE CAPITAL, LLC · IMMUNOVANT INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1601086","quarter":"2026Q2","cusip":"45258J102"}

get_institutional_manager_history
{"cik":"1601086","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.